This cash-strapped company is shifting from its roots in cancer drug development to focus on cosmetic treatments.
This cash-strapped company is shifting from its roots in cancer drug development to focus on cosmetic treatments.
The UCW Newswire : Financial, Business and Tech NewsCopyright © Louis Velazquez. All Rights Reserved.